ArticleScientific reports2026
Comparable immunogenicity from murine blood collection methods in intranasal gonococcal vaccination with ACP and MtrE supports refinement of preclinical vaccine studies.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- An mRNA-Lipid Nanoparticle Platform Encoding the Conserved Outer Membrane Protein BamA Elicits Broadly Cross-Reactive Systemic and Mucosal Antibodies Against Antimicrobial-ResistantbioRxiv : the preprint server for biology · 2026Article
Corrections and comments
- Update of
Authors and funding
7 authors.
Funding
Abstract
Preclinical vaccine studies often rely on antibody titers and functional assays to assess immunogenicity, but the impact of blood collection methods on these immunological outcomes remains poorly characterized. Retro-orbital (RO) bleeding is commonly used in murine models but raises animal welfare concerns, prompting the adoption of saphenous vein (SV) sampling as a less invasive alternative. Here, we compared RO and SV blood collection methods in mice immunized intranasally with Neisseria gonorrhoeae vaccine candidates—Adhesin Complex Protein (ACP) and Multiple Transferable Resistance E protein (MtrE)—formulated with or without the CpG adjuvant. Epitope mapping confirmed that both antigens contain surface-accessible B- and T-cell epitopes, supporting their potential for inducing protective immunity. Across 45 comparisons of serum antibody subclasses, only three total IgG differences between RO and SV were statistically significant, indicating high concordance between methods. Human serum bactericidal activity titers were similarly robust across both sampling techniques. In lysozyme inhibition assays, pooled SV sera from rACP + CpG-immunized mice restored significantly more human lysozyme activity compared to rACP alone, although individual-level analyses revealed no significant differences, despite a trend favoring CpG. These results demonstrate that SV blood collection yields immunologically comparable data to RO, while offering improved animal welfare. Adoption of SV sampling may enhance standardization, data quality, and ethical compliance in preclinical vaccine research.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.